# A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Study · id `cardio:ct-nct07567001` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07567001](<https://clinicaltrials.gov/study/NCT07567001>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07567001

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 5610 participants.

## Technical summary

Registry record NCT07567001. Randomized; quadruple masking; primary purpose treatment. Start 2026-05-11 (actual); primary completion 2029-07-23 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 5610 participants (planned count; ClinicalTrials.gov record NCT07567001, source copy `cardio:ctgov-nct07567001-2026-08-18`, retrieved 2026-10-26)
- Started: 2026-05-11 (actual) (ClinicalTrials.gov record NCT07567001, source copy `cardio:ctgov-nct07567001-2026-08-18`, retrieved 2026-10-26)
- Primary completion: 2029-07-23 (anticipated) (ClinicalTrials.gov record NCT07567001, source copy `cardio:ctgov-nct07567001-2026-08-18`, retrieved 2026-10-26)
- Completion: 2029-08-15 (anticipated) (ClinicalTrials.gov record NCT07567001, source copy `cardio:ctgov-nct07567001-2026-08-18`, retrieved 2026-10-26)
- Countries: United States; Argentina; Australia; Brazil; Bulgaria; Canada; China; Czechia; Denmark; France; Germany; Greece; India; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; Poland; Puerto Rico; South Africa; South Korea; Spain; Taiwan; Türkiye; United Kingdom (ClinicalTrials.gov record NCT07567001, source copy `cardio:ctgov-nct07567001-2026-08-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07567001-2026-08-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Acronym: HF-POLARIS
- Condition: Obesity
- Condition: Heart Failure
- Intervention (Drug): NNC0487-0111
- Intervention (Drug): Placebo
- Lead sponsor: Novo Nordisk A/S
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Novo Nordisk (`cardio:novo-nordisk`)

## Provenance

Content hash: e0244117776379c45040d538fd96b66cbee5eddc0acda40f3a4639862b7477ef
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
